FR2757400B1 - APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS - Google Patents
APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORSInfo
- Publication number
- FR2757400B1 FR2757400B1 FR9615649A FR9615649A FR2757400B1 FR 2757400 B1 FR2757400 B1 FR 2757400B1 FR 9615649 A FR9615649 A FR 9615649A FR 9615649 A FR9615649 A FR 9615649A FR 2757400 B1 FR2757400 B1 FR 2757400B1
- Authority
- FR
- France
- Prior art keywords
- antiglucocorticoidal
- psychosis
- compounds
- treatment
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9615649A FR2757400B1 (en) | 1996-12-19 | 1996-12-19 | APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS |
PCT/FR1997/002321 WO1998026785A1 (en) | 1996-12-19 | 1997-12-17 | Use of mifepristone for the treatment of psychoses and addictive behaviours |
EP97952079A EP0918525A1 (en) | 1996-12-19 | 1997-12-17 | Use of mifepristone for the treatment of psychoses and addictive behaviours |
EP97952078A EP0892641A1 (en) | 1996-12-19 | 1997-12-17 | Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours |
AU55633/98A AU5563398A (en) | 1996-12-19 | 1997-12-17 | Use of mifepristone for the treatment of psychoses and addictive behaviours |
AU55632/98A AU5563298A (en) | 1996-12-19 | 1997-12-17 | Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours |
PCT/FR1997/002320 WO1998026783A1 (en) | 1996-12-19 | 1997-12-17 | Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9615649A FR2757400B1 (en) | 1996-12-19 | 1996-12-19 | APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2757400A1 FR2757400A1 (en) | 1998-06-26 |
FR2757400B1 true FR2757400B1 (en) | 1999-12-17 |
Family
ID=9498861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9615649A Expired - Fee Related FR2757400B1 (en) | 1996-12-19 | 1996-12-19 | APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP0892641A1 (en) |
AU (2) | AU5563398A (en) |
FR (1) | FR2757400B1 (en) |
WO (2) | WO1998026785A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU747956B2 (en) | 1997-10-06 | 2002-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychosis associated with glucocorticoid related dysfunction |
EP1726307A3 (en) * | 1997-10-06 | 2007-04-04 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychosis associated with glucocorticoid related dysfunction |
SK287535B6 (en) | 1999-04-30 | 2011-01-04 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
US7713989B2 (en) | 2000-04-27 | 2010-05-11 | Dow Robert L | Glucocorticoid receptor modulators |
EP1201660B1 (en) | 2000-10-30 | 2005-08-31 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
MXPA04000692A (en) * | 2001-07-23 | 2004-04-21 | Corcept Therapeutics Inc | Methods for preventing antipsychotic-induced weight gain. |
US7326697B2 (en) * | 2002-04-29 | 2008-02-05 | Corcept Therapeutics, Inc. | Methods for increasing the therapeutic response to electroconvulsive therapy |
EP1862468A1 (en) | 2006-06-02 | 2007-12-05 | Bayer Schering Pharma Aktiengesellschaft | Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
DE102009034367A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-benzylidene derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034362A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034368A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-acyloxyalkylenephenyl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034366A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-methyleneoxyalkylene aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034525A1 (en) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034526A1 (en) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynylphenyl derivatives, process for their preparation and their use for the treatment of diseases |
DE102010007719A1 (en) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesterone receptor antagonist |
DE102010007722A1 (en) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesterone receptor antagonist |
EP2576582B1 (en) * | 2010-05-26 | 2019-09-18 | Corcept Therapeutics, Inc. | Treatment of muscular dystrophy |
CN118251415A (en) * | 2021-10-29 | 2024-06-25 | 清华大学 | Methods and products for treating or diagnosing schizophrenia |
CN114652730A (en) * | 2021-12-08 | 2022-06-24 | 中国科学院深圳先进技术研究院 | Use of mifepristone for intervention and treatment of nicotine addiction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU687088B2 (en) * | 1993-08-04 | 1998-02-19 | Merck Sharp & Dohme B.V. | Antiglucocorticoid steroids for the treatment of anxiety disorders |
FR2718354B1 (en) * | 1994-04-08 | 1996-05-03 | Roussel Uclaf | Application of the anti-glucocorticoid compounds for the preparation of medicaments intended for the prevention or the treatment of the manifestations linked to the narcotic withdrawal syndrome and the compositions containing them. |
-
1996
- 1996-12-19 FR FR9615649A patent/FR2757400B1/en not_active Expired - Fee Related
-
1997
- 1997-12-17 EP EP97952078A patent/EP0892641A1/en not_active Withdrawn
- 1997-12-17 EP EP97952079A patent/EP0918525A1/en not_active Withdrawn
- 1997-12-17 AU AU55633/98A patent/AU5563398A/en not_active Abandoned
- 1997-12-17 WO PCT/FR1997/002321 patent/WO1998026785A1/en not_active Application Discontinuation
- 1997-12-17 WO PCT/FR1997/002320 patent/WO1998026783A1/en not_active Application Discontinuation
- 1997-12-17 AU AU55632/98A patent/AU5563298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0892641A1 (en) | 1999-01-27 |
WO1998026785A1 (en) | 1998-06-25 |
AU5563298A (en) | 1998-07-15 |
WO1998026783A1 (en) | 1998-06-25 |
FR2757400A1 (en) | 1998-06-26 |
AU5563398A (en) | 1998-07-15 |
EP0918525A1 (en) | 1999-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2757400B1 (en) | APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS | |
NO991381D0 (en) | Combination therapy for the treatment of psychoses | |
DK0736075T3 (en) | The antifouling agent | |
DE69421296D1 (en) | MELT TREATMENT | |
NO972909D0 (en) | Substituted azetidin-2-ones for the treatment of atherosclerosis | |
BR9505368A (en) | Cosmetic or dermatogogic composition water-in-oil | |
HUP0003851A3 (en) | Pharmaceutical composition for the treatment or prevention of glomerulopathy | |
DE69413051D1 (en) | DETERGENT COMPOSITIONS CONTAINING AGENTS FOR PREVENTING THE TURNING OF SILVER | |
BR9609445A (en) | Azetidinone derivatives in the treatment of atherosclerosis | |
FI963596A (en) | Reduction of excess chloride from the oxide in iron | |
ITMI931436A1 (en) | HOMOCINETIC REVOLVING JOINT | |
BR9604818A (en) | Combination compositions containing benazepril or benazeprilat and valsartan | |
ID16981A (en) | THE CONCENTRATES OF ENCER PEARLS | |
FI970205A0 (en) | The two-hybrid system | |
FI964809A0 (en) | In the case of use of the processing unit | |
ID17201A (en) | PROCESSES AND TOOLS FOR SKIN TREATMENT AND THE LIKE | |
KR950011076U (en) | Bearing detacher | |
BR9103853A (en) | COATING OR COATING STONE | |
FR2701976B1 (en) | Work protected from bad weather, in particular work for the burial of waste. | |
KR970054943U (en) | The Ossuary Complex of the Ossuary Hall | |
FI960317A0 (en) | Procedure for the treatment of hazardous waste | |
KR940025597U (en) | Outlet safeguard | |
KR960007445U (en) | The outer handle of the car door | |
KR950006369U (en) | Industrial Water Treatment | |
KR960021252U (en) | Torque limiter built-in reducer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
ST | Notification of lapse |
Effective date: 20111209 |